Form 483

Klarity Medical Products LLC Form 483, 2021-07-09

FDA issued a Form 483 to Klarity Medical Products LLC on 2021-07-09 with 7 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health7 observations

Klarity Medical Products LLC · Heath, United States · Issued July 9, 2021

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Jul 2021
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Javonica F Penn

9 Jul 2021
21 CFR 820.181

DMR - not or inadequately maintained

Cited by Javonica F Penn

9 Jul 2021
21 CFR 820.184

Lack of or inadequate DHR procedures

Cited by Javonica F Penn

9 Jul 2021
21 CFR 820.25(b)

Training - Lack of or inadequate procedures

Cited by Javonica F Penn

9 Jul 2021
21 CFR 820.40

Lack of procedures, or not maintained

Cited by Javonica F Penn

Inspected site

KMKlarity Medical Products LLCHeath, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.40Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.80(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere